DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Besonprodil
Besonprodil
Predictive Value of Parkinsonian Primates in Pharmacological Studies, a Comparison Between the Macaque, Marmoset and Squirrel Monkey I
(12) United States Patent (10) Patent N0.: US 7,964,607 B2 Verhoest Et A1
United States Patent (10 ) Patent No.: US 10,660,887 B2 Javitt (45 ) Date of Patent: *May 26 , 2020
New Use of Glutaminyl Cyclase Inhibitors
Pharmacology of a Novel Biased Allosteric Modulator for NMDA Receptors
WO 2011/089216 Al
(12) Patent Application Publication (10) Pub. No.: US 2012/0157420 A1 Schneider (43) Pub
Supplemental Figure
( 12 ) United States Patent
WO 2010/000073 Al
WO 2015/150957 Al 8 October 2015 (08.10.2015) P O P C T
(12) United States Patent (10) Patent No.: US 9.486.453 B2 Javitt (45) Date of Patent: Nov
Summary of the AOP
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Regulation of BDNF-Trkb Signaling and Potential Therapeutic Strategies for Parkinson's Disease
(12) Patent Application Publication (10) Pub. No.: US 2008/0234237 A1 MADDAFORD Et Al
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
(12) United States Patent (10) Patent No.: US 8,173,813 B2 Maddaford Et Al
Top View
WO 2010/024870 Al
United States Patent (10) Patent No.: US 9,642,855 B2 Galatsis Et Al
Convergent Functional Genomic Studies of Omega-3 Fatty Acids in Stress Reactivity, Bipolar Disorder and Alcoholism
Supptable2 Study Sum
M Áster En Biotecnología Y Biom Edicina
Tepzz 5 58¥Zb T
A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor Glun2b-Selective Antagonists
A Pharmacological Interactome Between COVID-19 Patient Samples and Human Sensory Neurons Reveals Potential Drivers of Neurogenic
A Novel Binding Mode Reveals Two Distinct Classes of NMDA Receptor Glun2b-Selective Antagonists S
Attachment 9.Pdf
Tepzz 88¥45 B9t